HIV prevention implant: what do patients and doctors really think?
NCT ID NCT05420207
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This study interviewed 69 men who have sex with men (MSM) and their primary care doctors in Texas to understand their thoughts on a future long-acting, implantable HIV prevention method (PrEP). The goal was to identify what would help people use it and what training doctors might need. No treatment was given; the study simply gathered opinions to guide future efforts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dell Medical School, UT-Austin
Austin, Texas, 78712, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
Conditions
Explore the condition pages connected to this study.